Access Restriction

Author Baber, N. S. ♦ Evans, D. W. ♦ Howitt, G. ♦ Thomas, M. ♦ Wilson, T. ♦ Lewis, J. A. ♦ Dawes, P. M. ♦ Handler, K. ♦ Tuson, R.
Source PubMed Central
Content type Text
File Format PDF
Language English
Difficulty Level Medium
Subject Domain (in DDC) Technology ♦ Medicine & health
Abstract A multicentre study of survivors of an anterior myocardial infarction is reported. The trial consisted of 720 patients and was a double-blind, placebo-controlled study with propranolol 40 mg three times a day. Trial entry was at two to 14 days (mean 8.5 days) and follow-up at one, three, and in most centres, six and nine months. The trial was designed to detect a 50 per cent reduction in mortality and this was not shown. The non-fatal reinfarction rate was similar in both groups. Subgroup analysis identified several prognostic risk factors for death, none of which interacted with treatment.
ISSN 00070769
Age Range above 22 year
Educational Use Research
Interactivity Type Expositive
Education Level UG and PG
Learning Resource Type Article
Publisher Date 1980-07-01
Journal British Heart Journal
Volume Number 44
Issue Number 1
Starting Page 96

Source: PubMed Central